FDA表示,已获悉爱德华兹生命科学发布相关函件,建议将部分用于Sapien M3经导管二尖瓣置换术的输送系统予以移除。
FDA表示,已获悉爱德华兹生命科学发布相关函件,建议将部分用于Sapien M3经导管二尖瓣置换术的输送系统予以移除。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.